PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.68%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
9.32%
Positive gross profit growth while QRVO is negative. John Neff would see a clear operational edge over the competitor.
43.39%
EBIT growth below 50% of QRVO's 810.08%. Michael Burry would suspect deeper competitive or cost structure issues.
33.50%
Operating income growth above 1.5x QRVO's 6.61%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
15.24%
Positive net income growth while QRVO is negative. John Neff might see a big relative performance advantage.
20.00%
Positive EPS growth while QRVO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
20.00%
Positive diluted EPS growth while QRVO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
45.37%
Slight or no buybacks while QRVO is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
42.90%
Slight or no buyback while QRVO is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-33.23%
Dividend reduction while QRVO stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-24.69%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-19.83%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-33.03%
Negative 10Y revenue/share CAGR while QRVO stands at 95.48%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-57.43%
Negative 5Y CAGR while QRVO stands at 27.97%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-63.08%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-37.86%
Negative 5Y OCF/share CAGR while QRVO is at 5.08%. Joel Greenblatt would question the firm’s operational model or cost structure.
-46.80%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
12.76%
Below 50% of QRVO's 1921.69%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-27.94%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-56.65%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
115.41%
Positive growth while QRVO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
42.97%
Positive 5Y equity/share CAGR while QRVO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
6.40%
Positive short-term equity growth while QRVO is negative. John Neff sees a strong advantage in near-term net worth buildup.
29.25%
Dividend/share CAGR of 29.25% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-1.57%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-33.25%
Negative near-term dividend growth while QRVO invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-2.35%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
8.42%
We show growth while QRVO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
6.96%
Asset growth above 1.5x QRVO's 1.09%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-25.51%
We have a declining book value while QRVO shows 3.14%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-1.07%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-3.44%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
5.47%
SG&A declining or stable vs. QRVO's 19.11%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.